Valuation: Manhattan Scientifics, Inc.

Market Cap 336K 301K 276K 250K 468K 31.86M 477K 3.3M 1.32M 16.76M 1.26M 1.23M 52.86M P/E 2022
-1.64x
P/E 2023 -1.25x
Enterprise Value 329K 294K 271K 245K 458K 31.2M 467K 3.23M 1.3M 16.41M 1.23M 1.21M 51.75M EV / Sales 2022
88,184,960x
EV / Sales 2023 -
Free-Float
100%
Yield 2022 *
-
Yield 2023 -
1 week+9,900.00%
Current month+9,900.00%
1 month+9,900.00%
3 months+9,900.00%
6 months+9,900.00%
Current year+9,900.00%
1 month 0
Extreme 1.0E-6
0
Current year 0
Extreme 1.0E-6
0
1 year 0
Extreme 1.0E-6
0
3 years 0
Extreme 1.0E-6
0.01
5 years 0
Extreme 1.0E-6
0.03
10 years 0
Extreme 1.0E-6
0.05
Manager TitleAgeSince
Chief Executive Officer 74 31/10/2007
President 89 31/12/1997
Director TitleAgeSince
Chairman 89 -
Chairman 74 31/10/2007
Change 5-day change 1-year change 3-year change Capi.($)
-.--%+9,900.00%+13.64%-97.44% 559
+0.03%+2.57%+18.97%+122.31% 41.44B
+0.63%+2.32%-48.34%-26.93% 40.09B
+7.89%+6.78%-26.58%-26.04% 34.55B
-0.77%-2.18%+46.16%+160.40% 23.02B
+0.49%-0.78%-4.19%-2.17% 16.02B
+1.56%+2.61%-21.95%-26.80% 11.83B
+1.50%+0.77%-6.66%+64.73% 8.93B
+0.88%-19.49%+45.95%+86.09% 7.53B
-4.29%-4.00%-24.10%-11.82% 6.27B
Average +0.79%+0.83%-0.71%+24.23% 18.97B
Weighted average by Cap. +1.59%+2.06%-6.32%+39.98%

Financials

2022 2023
Net sales 0.05 0.04 0.04 0.04 0.07 4.75 0.07 0.49 0.2 2.5 0.19 0.18 7.88 -
Net income -2.73M -2.44M -2.25M -2.04M -3.81M -259M -3.88M -26.82M -10.77M -136M -10.25M -10.03M -430M -1.16M -1.04M -960K -870K -1.63M -111M -1.66M -11.45M -4.59M -58.19M -4.37M -4.28M -184M
Net Debt -65K -58.21K -53.55K -48.52K -90.69K -6.17M -92.39K -639K -256K -3.25M -244K -239K -10.24M -7K -6.27K -5.77K -5.23K -9.77K -665K -9.95K -68.77K -27.61K -350K -26.27K -25.71K -1.1M
Projected Income Statement - Annual - Manhattan Scientifics, Inc.
Logo Manhattan Scientifics, Inc.
Manhattan Scientifics, Inc. is focused on technology transfer and commercialization of these transformative technologies. The Company operates as a technology incubator. Its business model is to identify significant technologies; acquire them or the rights to them; secure the services of inventors, engineers or other staff who were instrumental in their creation; provide or contract for suitable work facilities, laboratories, and other aids where appropriate; prototype the technologies to demonstrate proof of principle feasibility; secure patent and or other intellectual property protection; secure early customers for product trials where feasible and appropriate; and commercialize through licenses, sales or cooperative efforts with other manufacturing and distribution firms. Its business model is based on licensing metals technology to metals manufacturers. Its technologies are in a development phase.
Employees
1
Date Price Change Volume
  1. Stock Market
  2. Stocks
  3. MHTX Stock